Time to Onset of Gemcitabine-induced Thrombotic Microangiopathy in a Japanese Population: A Case Series and Large-scale Pharmacovigilance Analysis.

Takigawa, Masaki; Tanaka, Hiroyuki; Washiashi, Hiromi; Onoda, Toshihisa; Ishigami, Akihito; Ishii, Toshihiro

Takigawa, Masaki; Tanaka, Hiroyuki; Washiashi, Hiromi; Onoda, Toshihisa; Ishigami, Akihito; Ishii, Toshihiro.

Afiliação

Takigawa M; Department of Pharmacy, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan.
Tanaka H; Molecular Regulation of Aging, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan.
Washiashi H; Department of Practical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University, Funabashi, Japan.
Onoda T; Department of Practical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University, Funabashi, Japan.
Ishigami A; Department of Pharmacy, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan.
Ishii T; Department of Practical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University, Funabashi, Japan.

Cancer Diagn Progn ; 3(1): 115-123, 2023.

Article em En | MEDLINE | ID: mdl-36632593

Palavras-chave

Gemcitabine; Japan; Japanese Adverse Drug Event Report database; thrombotic microangiopathy; time to onset

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancer Diagn Progn Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão País de publicação: Grécia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google